☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Autism
Sangamo Signs a Worldwide License Agreement with Novartis to Develop Genomic Therapies for Three Neurodevelopmental Targets
July 30, 2020
Cognoa Collaborates with Autism Learning Partners for Screening App to Accelerate Early Diagnosis of Autism
February 12, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
